(Q44288438)

English

Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study (English)

1 reference

Europe PubMed Central

1 December 2017

0 references

0 references

cannabinoid receptor

0 references

author name string

Cory S Freedland

1

1 reference

Europe PubMed Central

1 December 2017

Christopher T Whitlow

2

1 reference

Europe PubMed Central

1 December 2017

Hilary R Smith

3

1 reference

Europe PubMed Central

1 December 2017

Linda J Porrino

4

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

1 December 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

1 December 2017

962

1 reference

Europe PubMed Central

1 December 2017

169-179

1 reference

Europe PubMed Central

1 December 2017

1-2

1 reference

Europe PubMed Central

1 December 2017

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Effects of food FR and food deprivation on disruptions in food-maintained performance of monkeys during phencyclidine withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Nicotine dependence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Adaptation of the quantitative 2-[14C]deoxyglucose method for use in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Functional mapping of the rat brain during drinking behavior: a fluorodeoxyglucose study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Neurobehavioural mechanisms of reward and motivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Activational role of cannabinoids on movement

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Inhibitory effects of SR141716A on G-protein activation in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

Evidence for cocaine dependence in monkeys following a prolonged period of exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

The Contribution of Basal Forebrain to Limbic — Motor Integration and the Mediation of Motivation to Action

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903999-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(02)03999-9

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44288438&oldid=2109169957"